Showing results (71-80 of 868) with videos related to
Sort By:
Pageof 87
Archives of Internal Medicine|February 1, 1981
Mesenteric hyaline plasma cell lymph node hyperplasia with amyloid depositsJ Garcia-SanMiguel, C Rozman, A Palacin, et al.British Journal of Haematology|March 1, 1986
Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significanceE Montserrat, J Sanchez-Bisono, N Viñolas, et al.Acta Haematologica|January 1, 1976
Oxymetholone effect of acute myeloblastic leukemia cells in vitroM Ribas-Mundo, J G San Miguel, C RozmanCancer Treatment Reports|May 1, 1986
Treatment of advanced resistant Hodgkin's disease with lomustine, etoposide, and prednimustineF Cervantes, J C Reverter, E Montserrat, et al.Human Genetics|December 15, 1976
Hereditary hemolytic anemia with erythrocyte pyrimidine 5'-nucleotidase deficiency in Spain. Clinical, biological and familial studiesJ L Vives-Corrons, E Montserrat-Costa, C RozmanNouvelle Revue Francaise D'Hematologie|January 1, 1988
Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stagesE Montserrat, N Viñolas, J C Reverter, et al.Bone Marrow Transplantation|January 23, 1999
Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBTC Solano, C Martinez, S Brunet, et al.Sangre|October 1, 1990
[Effect of the administration of rhGM-CSF in a patient with marrow aplasia resistant to immunosuppressive treatment]P Marín, M Rovira, C Sanz, et al.Leukemia & Lymphoma|July 28, 2016
Efficacy of ABVD Therapy in Resistant Hodgkin's DiseaseE Montserrat, J M Martí, J C Reverter, et al.Medicina Clinica|January 21, 1989
[Analysis of response to treatment. Considerations on changing prognostic variables (time-dependent)]C Rozman, E Montserrat, M Rozman, et al.Pageof 87